DexCom Inc. (DXCM) reported robust Q4 2025 earnings, surpassing Wall Street expectations with $1.26 billion in revenue, driven by strong sales of G7 and the new Stelo system. For the full year 2025, the company’s revenue reached $4.662 billion, exceeding guidance. DexCom reiterated its 2026 revenue guidance, citing continued market expansion and product innovation.
This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.
DexCom Inc. (DXCM) Reports Strong Performance While Maintaining Forward Outlook
DexCom Inc. (DXCM) reported robust Q4 2025 earnings, surpassing Wall Street expectations with $1.26 billion in revenue, driven by strong sales of G7 and the new Stelo system. For the full year 2025, the company’s revenue reached $4.662 billion, exceeding guidance. DexCom reiterated its 2026 revenue guidance, citing continued market expansion and product innovation.